Downregulation of the pro-apoptotic protein Bak is required for the ras-induced transformation of intestinal epithelial cells  by Rosen, Kirill et al.
Brief Communication 1331
Downregulation of the pro-apoptotic protein Bak is required for
the ras-induced transformation of intestinal epithelial cells
Kirill Rosen*, Janusz Rak*, Jing Jin†, Robert S. Kerbel*, Michael J. Newman‡
and Jorge Filmus*
Anoikis is a form of programmed cell death induced in
normal epithelial cells by detachment from the
extracellular matrix [1–3]. In epithelial cells of the
intestine and other organs, activated ras induces
resistance to anoikis [3,4], but the actual molecular
effectors directly involved in the apoptotic machinery
that execute or block anoikis have not yet been
identified. Bak, a pro-apoptotic member of the Bcl-2
family, is downregulated in a high proportion of
colorectal tumours [5]. In addition, Bak is an important
regulator of apoptosis in normal intestinal epithelial
cells [6,7]. Here, we show that activated ras induces the
downregulation of Bak in rat and human intestinal
epithelial cells. This ras-induced downregulation of Bak
expression could be suppressed by an inhibitor of
phosphatidylinositol (PI) 3-kinase, an enzyme already
implicated in ras-induced resistance to anoikis [8].
Ectopic expression of Bak in ras-transformed rat
intestinal epithelial IEC-18 cells inhibited ras-induced
resistance to anoikis and significantly reduced their
tumorigenicity. We conclude, therefore, that the ability of
ras to downregulate Bak, and the consequent resistance
to anoikis, are essential components of the transforming
capacity of this oncogene in intestinal epithelial cells.
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Results and discussion
To investigate the effect of activated ras on the expression
of Bak in intestinal epithelial cells, we first compared the
levels of Bak in the parental non-malignant IEC-18 cells
and in IEC-ras-3 and IEC-ras-4, two clones of cells that
were independently generated by transfection of IEC-18
cells with activated H-ras [9,10]. In monolayer culture, ras-
transformed clones expressed significantly lower amounts of
Bak than the IEC-18 cells (Figure 1a). A similar reduction of
Bak expression was observed when cells were placed in sus-
pension (data not shown). The ras-induced downregulation
of Bak was also observed by northern blot analysis (see Sup-
plementary material published with this paper on the inter-
net). In addition, we also studied the effect of activated ras
on Bak expression in a clone obtained by transfecting IEC-
18 cells with a vector carrying an activated H-ras gene under
the control of a dexamethasone-inducible mouse mammary
tumour virus (MMTV) promoter (MMTV–ras) [9]. In
agreement with the results obtained with the clones that
constitutively expressed activated H-ras, Bak levels were
downregulated upon treatment of the MMTV–ras clone
with dexamethasone (Figure 1b). Similar treatment of
parental IEC-18 cells did not affect Bak levels (Figure 1c).
To verify that ras-induced downregulation of Bak also
occurs in human colorectal cancer cells, we examined Bak
Figure 1
Expression of activated H-ras and K-ras in intestinal epithelial cells
results in a reduction of levels of Bak. (a) Western blot analysis of Bak
in IEC-18 cells and two independently derived H-ras-transformed
clones, IEC-ras-3 (ras-3) and IEC-ras-4 (ras-4). (b) IEC-18 cells
carrying the H-ras gene under the control of the dexamethasone-
inducible MMTV promoter, before (0 h) and after induction with 1 µM
dexamethasone (dex) for 24, 36 and 48 h. The same cell lysates were
independently assessed for the expression of H-ras. (c) IEC-18 cells
before and after treatment with 1 µM dexamethasone for 48 h. In (a–c),
the membrane was also incubated with anti-Cdk4 antibody as a
loading control. (d) Western blot analysis of the colorectal tumor cell
line HCT 116, which carries activated K-ras, and its derivative cell line
HKh-2, in which the activated K-ras allele was deleted by targeted
disruption. The membrane was incubated with anti-E-cadherin antibody
as a loading control. A polyclonal Bak antibody (UBI) generated
against a synthetic peptide corresponding to residues 23–37 of
human Bak (also present in the mouse homologue) was used in (a–d).
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expression in the highly tumorigenic HCT 116 cell line,
which carries an activated K-ras gene, and in its derivative
cell line Hkh-2, in which the activated K-ras allele has
been deleted by homologous recombination [11]. Western
blot analysis showed that the ras-containing HCT 116
cells express considerably less Bak than the Hkh-2 cells
(Figure 1d). As with the IEC cells, the ras-induced down-
regulation of Bak was also observed by northern blot
analysis (see Supplementary material). As colorectal
tumours have high frequencies of activating K-ras muta-
tions, our observation that activated K-ras is responsible
for the reduction of Bak expression in the HCT 116 cells
suggests that ras mutations are, at least in part, responsible
for the reported downregulation of Bak expression in a
large proportion of human colorectal tumours [5].
To investigate whether the inhibition of Bak expression
has a causal role in ras-induced resistance to anoikis in
IEC cells, we restored high levels of Bak in the trans-
formed IEC-ras-3 cell line by transfection with a human
Bak expression vector. We generated four independent
clones (designated Bak43, 45, 55 and 1) that expressed
levels of Bak comparable to those observed in the IEC-18
cells, and significantly higher than those of IEC-ras-3 and
the clones transfected with vector control (designated
Zeo2, 22 and 53). All transfected clones were morphologi-
cally similar to the parental IEC-ras-3 cells, with no
obvious changes in their growth rate in monolayer culture.
The levels of activated ras in these clones remained
unchanged (Figure 2a).
To investigate the effect of exogenous Bak expression on
anoikis, Bak clones and control Zeo clones were cultured
as monolayers or in suspension, and apoptosis was assessed
using the cell death enzyme-linked immunosorbent assay
(ELISA) which measures the release of oligonucleosomes
into the cytoplasm. In monolayer culture, none of the Bak-
transfected clones showed a noticeable increase in cell
death compared with IEC-ras-3 clones transfected with
vector control (Figure 2b). In suspension culture, however,
the Bak-transfected clones displayed a significant increase
in apoptosis (Figure 2b). Consistent with this result, we
found that the ability of the Bak-transfected IEC-ras
clones to grow in soft agar was strongly inhibited (~70%;
1332 Current Biology, Vol 8 No 24
Figure 2
ras
-3
Ze
o2
Ze
o2
2
Ze
o5
3
Ba
k4
3
Ba
k4
5
Ba
k5
5
Ba
k1
IE
C-
18
0.0
0.5
1.0
1.5
O
D
 (a
rb
itr
ar
y 
un
its
) Monolayer
Suspension
Monolayer
Suspension
Cell death ELISA
ras
-3
Ze
o2
Ze
o2
2
Ze
o5
3
Ba
k4
3
Ba
k4
5
Ba
k5
5
Ba
k1
IE
C-
18
ras
-3
Ze
o2
Ze
o2
2
Ze
o5
3
Ba
k4
3
Ba
k4
5
Ba
k5
5
Ba
k1
IE
C-
18
0
200
400
600
800
1000
1200
1400
1600
1800
N
um
be
r o
f c
ol
on
ie
s
Anchorage-independent growth
M
MT
V–
ras
–B
ak
M
MT
V–
ras
–Z
eo
M
MT
V–
ras
–B
ak
M
MT
V–
ras
–Z
eo
M
MT
V–
ras
–B
ak
M
MT
V–
ras
–Z
eo

0.0
0.2
0.4
0.6
0.8
1.0
1.2
1.4
O
D
 (a
rb
itr
ar
y 
un
its
)
+ Dex
Cell death ELISA
Bak
–Dex + – +
Cdk4
(a)
(b) (d)
(c) (e)
H-Ras
Bak
Cdk4
H-Ras
   Current Biology   
Ectopic expression of Bak in the ras-transformed intestinal epithelial
cells results in increased susceptibility to anoikis. (a) Western blot
analysis of the levels of Bak in IEC-ras-3 clones transfected with a
human Bak expression vector (Bak43, 45, 55 and 1) or the zeocin-
resistance (zeo) gene alone (Zeo2, 22 and 53). The membrane was
incubated with anti-Cdk4 antibody as a loading control, and the same
cell lysates were also assessed for the expression of H-Ras.
(b) Analysis of apoptosis in IEC-ras-3 and Bak-transfected clones.
Cells were cultured overnight in monolayer or suspension and the
amount of nucleosomal DNA in the cytoplasm was measured by the
cell death ELISA. (c) Growth in anchorage-independent conditions.
Cells were plated in soft agar, colonies were allowed to form for
10 days and counted. (d) Western blot analysis of the levels of Bak
expression in MMTV–ras clones transfected with Bak or the zeo gene
alone in the presence (+) or absence (–) of 1 µM dexamethasone
(dex). The membrane was incubated with anti-Cdk4 antibody as a
loading control, and the same cell lysates were also assessed for the
expression of H-Ras. (e) The cells described in (d) were analysed for
apoptosis as in (b). Error bars in (b,c,e) represent the standard error of
two independent experiments.
Figure 2c). We further confirmed the effect of exogenous
Bak on anoikis using an MMTV–ras clone transfected with
a Bak expression vector (MMTV–ras–Bak). In the absence
of dexamethasone, this clone expressed significantly more
Bak than the uninduced control clone transfected with
vector alone (MMTV–ras–Zeo). Although both clones
maintained similar ability to induce the expression of H-
ras and downregulate Bak in response to dexamethasone,
the levels of Bak in the dexamethasone-treated MMTV-
ras-Bak cells were significantly higher than those of dex-
amethasone-treated MMTV–ras–Zeo cells (Figure 2d). As
shown for the IEC-ras clones, the ectopic expression of
Bak strongly diminished the ras-induced resistance to
anoikis in the dexamethasone-treated MMTV–ras–Bak
cells (Figure 2e). 
It can be concluded, therefore, that ras-transformed IEC
cells can be rendered sensitive to anoikis by restoring
higher levels of Bak. It is noteworthy that this reversal of
resistance to anoikis in Bak transfectants was significant
but not complete, suggesting that activated ras may regu-
late, in addition to Bak, other effector molecules of the
apoptotic machinery involved in anoikis. As transfected
Bak did not induce the apoptosis of IEC-ras-3 cells in
monolayer culture, it can be concluded that the reduction
of Bak levels per se is not sufficient to inactivate the apop-
totic machinery in intestinal epithelial cells. Rather, it can
be proposed that, in the parental IEC-18 cells, a certain
threshold amount of Bak is required for the induction of
apoptosis triggered by the absence of survival signals nor-
mally generated by integrin–extracellular matrix (ECM)
interactions. Hence, when the levels of Bak are reduced,
for example as a result of ras activation, the integrin-
induced death signal becomes ineffective. 
As susceptibility to apoptosis is believed to be an impor-
tant determinant of the malignant phenotype, we com-
pared the tumorigenicity in nude mice of the IEC-ras-3
cells, of a clone transfected with vector control, and of
three Bak-transfected clones (Bak45, 55 and 1). Figure 3a
shows that the Bak clones were significantly less tumori-
genic than the parental IEC-ras cells and the clone trans-
fected with vector control. Because the Bak-transfected
clones, especially Bak45 and Bak55, retained some
tumorigenicity, we investigated whether cells derived
from these tumours acquired a selective growth advan-
tage through the reduction of Bak expression. Tumours
derived from clones Bak45 and Bak55 were removed and
cell lines re-established. In the case of the Bak45 clone,
three out of four tumour-derived cell lines expressed sig-
nificantly less Bak than the originally injected cell popu-
lation (Figure 3b). This trend was even more pronounced
in clone Bak55, for which all of the tumour-derived cell
lines displayed lower levels of Bak. These data clearly
suggest that low Bak expression provides a selective
growth advantage for ras-transformed tumour cells in
vivo. Therefore, our results clearly demonstrate that mol-
ecular changes that affect susceptibility to anoikis
without affecting survival in monolayer culture can have a
significant impact on tumorigenicity.
In Madin–Darby canine kidney (MDCK) epithelial cells,
ras inhibits anoikis through the activation of a PI 
3-kinase–protein kinase B (PKB) signaling pathway, but
not through a mitogen-activated protein (MAP) kinase
pathway [8]. We therefore investigated whether PI 
3-kinase is also involved in the ras-induced downregula-
tion of Bak and inhibition of anoikis in IEC cells. IEC-ras-
3 cells were treated with the PI 3-kinase inhibitor
LY 294002 at a concentration known to efficiently sup-
press PI 3-kinase (40 µM) [12]. After such treatment, IEC-
ras-3 cells displayed a significant increase in the levels of
Bak (Figure 4a). Similar upregulation of Bak by
LY 294002 was observed in the dexamethasone-treated
MMTV–ras cells (see Supplementary material). The inhi-
bition of PI 3-kinase activity by LY 294002 treatment of
the ras-transformed cells was confirmed by measuring
PKB activity (see Supplementary material). In contrast to
the results obtained with LY 294002, treatment of IEC-
ras-3 cells with PD 98059, a specific inhibitor of the MAP
kinase kinase MEK [13,14], did not abrogate ras-induced
downregulation of Bak (Figure 4b).
In good agreement with our studies on the effect of
LY 294002 on Bak expression, this inhibitor significantly
reduced the resistance of IEC-ras cells to anoikis
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Figure 3
Ectopic expression of Bak in ras-transformed IEC cells results in
reduced tumorigenicity. (a) The indicated cell lines were injected
subcutaneously into nude mice and tumour volumes were measured at
the indicated time points. The number of mice (n) used in each
experiment is indicated. This experiment was repeated twice with
similar results. (b) Western blot analysis of Bak in tumours derived from
Bak-transfected clones Bak45 and Bak55. Tumours were extracted
from mice, cell lines re-established in tissue culture, and levels of Bak
were compared with those of the same clones before injection.
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(Figure 4c). PD 98055, on the other hand, did not affect
this process (Figure 4c). Collectively, these results suggest
that PI 3-kinase is a mediator of the ras-induced downreg-
ulation of Bak expression and resistance to anoikis. In this
regard, it is important to note that PKB, an enzyme acti-
vated by PI 3-kinase, has recently been shown to suppress
apoptosis of neuronal cells by phosphorylating Bad,
another pro-apoptotic member of the Bcl-2 family [15].
Phosphorylation of Bad by PKB has also been reported in
the case of lymphoid progenitor cells [16]. We are cur-
rently investigating whether, in addition to the effect on
Bak expression, activated ras can induce Bad phosphoryla-
tion in intestinal epithelial cells. 
This paper provides support for the notion that the con-
tribution of the ras oncogene to malignant transformation
of intestinal epithelial cells is not limited to its effects on
cell proliferation. We have already reported that activated
ras induces cyclin D1 overexpression, and that this
induction is required for the deregulation of cell prolifer-
ation [10]. However, the ras-induced deregulation of the
cell cycle will have a limited impact on the malignant
growth of intestinal epithelial cells, unless these cells
acquire the capacity to survive without being attached to
the basement membrane, because this is an essential
requirement for invasion. It can be concluded, therefore,
that the ability of ras to induce Bak downregulation, and
the consequent resistance to anoikis, are critical compo-
nents of the transforming capacity of this oncogene in
intestinal epithelial cells.
Supplementary material
Additional figures showing the downregulation of Bak mRNA by acti-
vated ras and the upregulation of Bak by LY 294002 upon induction of
ras are published with this paper on the internet.
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Figure 4
Reduction of Bak expression and resistance to anoikis caused by
oncogenic ras in IEC cells can be prevented by the PI 3-kinase
inhibitor LY 294002 but not by the MEK inhibitor PD 98059. IEC-ras-3
cells were incubated for the indicated time periods with 
(a) LY 294002 and (b) PD 98059 and the expression of Bak was
analysed by western blotting. (c) IEC-ras-3 cells were incubated
overnight in monolayer and in suspension in the presence of 
LY 294002 and PD 98059 and the amount of nucleosomal DNA in the
cytoplasm was assayed by cell death ELISA. DMSO was added to the
untreated cells in (a–c). The error bars in (c) represent the standard
error of two independent experiments.
Ve
hic
le
LY
 2
94
00
2
PD
 9
80
59
0.0
0.1
0.2
0.3
0.4
Ve
hic
le
LY
 2
94
00
2
PD
 9
80
59
0.0
0.1
0.2
0.3
0.4
O
D
 (a
rb
itr
ar
y 
un
its
)
O
D
 (a
rb
itr
ar
y 
un
its
)Monolayer Suspension
Time (h):(a)
(b)
(c)
Bak
0 1 2 6 10 24
Time (h):
Bak
0 1 2 6 17
   Current Biology   
Downregulation of the pro-apoptotic protein Bak is required for
the ras-induced transformation of intestinal epithelial cells
Kirill Rosen, Janusz Rak, Jing Jin, Robert S. Kerbel, Michael J. Newman 
and Jorge Filmus
Current Biology 23 November 1998, 8:1331–1334
S1
Activated ras downregulates Bak mRNA
The effect of ras activation on the levels of Bak transcripts
was assessed by northern blot analysis. In both IEC-18
and HCT 116 cell lines, the presence of activated ras cor-
related with lower levels of Bak mRNA (Figure S1).
LY 294002 upregulates Bak in dexamethasone-treated
MMTV–ras cells
The effect of LY 294002 was also studied in MMTV–ras
cells. Treatment with this inhibitor upregulated Bak in
the dexamethasone-treated (ras-expressing) cells
(Figure S2c). A similar treatment of IEC-18 or uninduced
MMTV–ras cells, on the other hand, did not alter Bak
expression (Figure S2a,c). This could be because these
cell lines already express high levels of Bak and may have
a limited capacity to upregulate the protein further. To
confirm that activated ras induces PI 3-kinase activity in
IEC cells, and that LY 294002 was acting as an inhibitor of
PI 3-kinase, the activity of PKB, a downstream target of PI
3-kinase, was measured in IEC cells expressing constitu-
tive and inducible ras. Figure S2b,c shows that activated
ras strongly induces PKB activity in a PI 3-kinase-depen-
dent manner, because this ras-induced activation was
inhibited by LY 294002, whereas the expression of PKB
remained essentially unchanged.
Reference
S1. Staveley BE, Ruel L, Jin J, Stambolic V, Mastronardi FG, Heitzler P, et
al.: Genetic analysis of protein kinase B (AKT) in Drosophila. Curr
Biol 1998, 8:599-602.
Supplementary material
Figure S1
Northern blot analysis of Bak in (a) IEC-18, IEC-ras-3 (ras-3) and IEC-
ras-4 (ras-4) cells, and (b) Hkh-2 and HCT 116 cells. Glyceraldehyde-
3-phosphate dehydrogenase (GAPDH) was used as a loading control.
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Figure S2
(a) IEC-18 and IEC-ras-3 cells were treated
with LY 294002 for the indicated time
periods and the expression of Bak was
analysed by western blotting. (b) IEC-18 and
ras-3 cells with (+) or without (–) treatment
with LY 294002 (LY) for 12 h were lysed,
PKBα was immunoprecipitated (IP), and
incubated with crosstide, a fragment of
glycogen synthase kinase 3 (GSK3) that is a
natural substrate of PKB, in the presence of
[γ-32P]ATP [S1]. The reaction mixture was
analysed by SDS–PAGE, and radioactively
labeled crosstide detected by
autoradiography. Total levels of PKB were
also assessed by western blotting.
(c) MMTV–ras cells uninduced (–) or induced
(+) with dexamethasone (dex) for 48 h, and
with (+) or without (–) LY 294002 treatment
(LY) for 12 h, were assessed as in (a,b) for
Bak levels, PKB activity and PKB expression.
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